TheraCyte Cell Encapsulation System IDE Slated For Second Quarter
This article was originally published in The Gray Sheet
Executive Summary
TheraCyte, Inc. plans to file an investigational device exemption with FDA during the second quarter for a Phase I study intended to evaluate the TheraCyte encapsulated cell technology implant system.